Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 222

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 222
---
 cause fluctuations in the trading price of PubCo’s securities include the following: •actual or anticipated fluctuations in PubCo’s financial condition or results of operations; •variance in PubCo’s financial performance from the expectations of securities analysts; •changes in PubCo’s projected operating and financial results; •changes in laws or regulations applicable to PubCo’s business; •announcements by PubCo or its competitors of significant business developments, acquisitions or new offerings; •sales of PubCo’s securities by its shareholders or warrant holders, as well as the anticipation of lockup releases; •PubCo’s involvement in material litigation; •conditions or developments affecting the NEV and e -fuelindustries in China; •changes in senior management or key personnel; •the trading volume of PubCo’s securities; •general economic and market conditions; and •other events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events. Outstanding Finnovate Warrants will be assumed by PubCo and converted into corresponding warrants to purchase PubCo ADSs and PubCo Ordinary Shares, which will increase the number of shares eligible for future resale in the public market and result in dilution to PubCo’s shareholders. Outstanding Finnovate Warrants will be assumed by PubCo and converted into corresponding warrants to purchase an aggregate of 21,737,500 PubCo Ordinary Shares, including those represented by PubCo ADSs. The Assumed Warrants will not become exercisable until 30 days after the Closing, and will expire five years after the completion of the Business Combination. Each Assumed Warrant will entitle the holder thereof to purchase one PubCo ADS or PubCo Ordinary Share at a price of US$11.50 per whole share, subject to adjustment. The Assumed Warrants may be exercised only for a whole number of PubCo ADSs or PubCo Ordinary Shares. To the extent such warrants are exercised, additional PubCo ADSs and PubCo Ordinary Shares will be issued, which will result in dilution to the then -existingholders of PubCo ADSs and PubCo Ordinary Shares and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of PubCo ADSs. The exclusive forum provision in the warrant agreement can result in increased costs to investors to bring a claim. The warrant agreement relating to the Assumed Warrants will provide that PubCo agrees that any action, proceeding or claim against it arising